GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pentixapharm Holding AG (XTER:PTP) » Definitions » Cash From Other Investing Activities

Pentixapharm Holding AG (XTER:PTP) Cash From Other Investing Activities : €-0.41 Mil (TTM As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Pentixapharm Holding AG Cash From Other Investing Activities?

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Pentixapharm Holding AG's cash from other investing activities for the six months ended in Jun. 2024 was €0.00 Mil. It means Pentixapharm Holding AG received €0.00 Mil from other investing activities. Pentixapharm Holding AG's cash from other investing activities for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.41 Mil.


Pentixapharm Holding AG Cash From Other Investing Activities Historical Data

The historical data trend for Pentixapharm Holding AG's Cash From Other Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pentixapharm Holding AG Cash From Other Investing Activities Chart

Pentixapharm Holding AG Annual Data
Trend Dec21 Dec22 Dec23
Cash From Other Investing Activities
- -4.07 -

Pentixapharm Holding AG Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24
Cash From Other Investing Activities - - - -0.41 -

Pentixapharm Holding AG Cash From Other Investing Activities Calculation

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Cash From Other Investing Activities for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pentixapharm Holding AG Cash From Other Investing Activities Related Terms

Thank you for viewing the detailed overview of Pentixapharm Holding AG's Cash From Other Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.


Pentixapharm Holding AG Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
Robert-Rossle-Street 10, Berlin, DEU
Pentixapharm Holding AG is a clinical-stage biopharmaceutical company active in the field of research and development of radiopharmaceuticals for diagnostic and therapeutic applications. Radiopharmaceuticals are medical substances containing radioactive elements used in nuclear medicine to diagnose or treat diseases. Its clinical pipeline encompasses PentixaTher, a Yttrium-90 based therapeutic against non-Hodgkin lymphomas (NHL), and PentixaFor, a Gallium-68-based companion diagnostic.

Pentixapharm Holding AG Headlines

No Headlines